【24h】

Protein S-palmitoylation and cancer

机译:蛋白S-棕榈酰化与癌症

获取原文
获取原文并翻译 | 示例
           

摘要

Protein S-palmitoylation is a reversible posttranslational modification of proteins with fatty acids, an enzymatic process driven by a recently discovered family of protein acyltransferases (PATs) that are defined by a conserved catalytic domain characterized by a DHHC sequence motif. Protein S-palmitoylation has a prominent role in regulating protein location, trafficking and function. Recent studies of DHHC PATs and their functional effects have demonstrated that their dysregulation is associated with human diseases, including schizophrenia, X-linked mental retardation, and Huntington's Disease. A growing number of reports indicate an important role for DHHC proteins and their substrates in tumorigenesis. Whereas DHHC PATs comprise a family of 23 enzymes in humans, a smaller number of enzymes that remove palmitate have been identified and characterized as potential therapeutic targets. Here we review current knowledge of the enzymes that mediate reversible palmitoylation and their cancer-associated substrates and discuss potential therapeutic applications. (C) 2015 Elsevier B.V. All rights reserved.
机译:蛋白质S-棕榈酰化是用脂肪酸对蛋白质进行的可逆翻译后修饰,这是由最近发现的蛋白质酰基转移酶(PAT)家族驱动的酶促过程,该家族由以DHHC序列基序为特征的保守催化结构域定义。蛋白质S-棕榈酰化在调节蛋白质的位置,运输和功能方面具有重要作用。 DHHC PAT及其功能作用的最新研究表明,它们的调节失调与人类疾病有关,包括精神分裂症,X连锁智力低下和亨廷顿舞蹈病。越来越多的报道表明DHHC蛋白及其底物在肿瘤发生中具有重要作用。 DHHC PATs在人体内包含23种酶,但已鉴定出较少的去除棕榈酸酯的酶,并将其表征为潜在的治疗靶标。在这里,我们回顾了介导可逆棕榈酰化酶及其与癌症相关的底物的酶的当前知识,并讨论了潜在的治疗应用。 (C)2015 Elsevier B.V.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号